Cardiovascular Systems Inc (CSII):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Cardiovascular Systems Inc (CSII) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6477
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company’s products include peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accessories. Its peripheral artery disease system is a percutaneous orbital atherectomy system that is used as therapy for occlusive atherosclerotic disease in peripheralarteries and stenotic material from artificial arteriovenous dialysis fistulae. CSI offers accessories such as guide wire, lubricant, pump and tape. It has developed orbital atherectomy systems technology for both peripheral and coronary commercial applications. The company serves patients suffering from peripheral arterial disease and coronary artery diseases. It markets its products through its network of distributors. CSI is headquartered in St. Paul, Minnesota, the US.

Cardiovascular Systems Inc (CSII) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cardiovascular Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cardiovascular Systems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cardiovascular Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cardiovascular Systems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Cardiovascular Systems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cardiovascular Systems Inc, Medical Equipment, Deal Details 10
Partnerships 10
Cardiovascular Systems Enters into Co-Development Agreement with Aerolase 10
Cardiovascular Systems Enters into Distribution Agreement with OrbusNeich 11
Cardiovascular Systems Enters into Agreement with OrbusNeich 12
Cardiovascular Systems Enters into Distribution Agreement with Medikit 13
Equity Offering 14
Cardiovascular Systems Completes Public Offering Of Shares For US$101.7 Million 14
Cardiovascular Systems Completes Public Offering Of Shares For US$40.5 Million 16
Cardiovascular Systems Completes Public Offering Of Common Stock For US$16 Million 17
Cardiovascular Systems Inc – Key Competitors 19
Cardiovascular Systems Inc – Key Employees 20
Cardiovascular Systems Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Financial Announcements 22
Jul 30, 2018: Cardiovascular Systems Reports Fiscal 2018 Fourth-Quarter Financial Results 22
May 02, 2018: Cardiovascular Systems Reports Fiscal 2018 Third-Quarter Financial Results 24
Feb 07, 2018: Cardiovascular Systems Reports Fiscal 2018 Second-Quarter Financial Results 26
Oct 25, 2017: Cardiovascular Systems Reports Fiscal 2018 First-Quarter Financial Results 28
Aug 02, 2017: Cardiovascular Systems Reports Fiscal 2017 Fourth-Quarter Financial Results 30
May 03, 2017: Cardiovascular Systems Reports Fiscal 2017 Third-Quarter Financial Results 32
Jan 25, 2017: Cardiovascular Systems Reports Fiscal 2017 Second-Quarter Financial Results 34
Corporate Communications 36
Feb 02, 2018: Cardiovascular Systems Appoints Jeff Points as Chief Financial Officer 36
Jan 24, 2018: Cardiovascular Systems Appoints Rhonda Robb as New Chief Operating Officer 37
Feb 21, 2017: Cardiovascular Systems Announces Healthcare Veteran Martha Goldberg Aronson Joins Board of Directors 38
Other Significant Developments 39
Sep 18, 2017: Cardiovascular Systems Announces Anticipated Revenue Impact from Hurricanes Harvey and Irma 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Cardiovascular Systems Inc, Medical Equipment, Key Facts, 2018 2
Cardiovascular Systems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cardiovascular Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cardiovascular Systems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cardiovascular Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cardiovascular Systems Inc, Deals By Market, 2012 to YTD 2018 8
Cardiovascular Systems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cardiovascular Systems Enters into Co-Development Agreement with Aerolase 10
Cardiovascular Systems Enters into Distribution Agreement with OrbusNeich 11
Cardiovascular Systems Enters into Agreement with OrbusNeich 12
Cardiovascular Systems Enters into Distribution Agreement with Medikit 13
Cardiovascular Systems Completes Public Offering Of Shares For US$101.7 Million 14
Cardiovascular Systems Completes Public Offering Of Shares For US$40.5 Million 16
Cardiovascular Systems Completes Public Offering Of Common Stock For US$16 Million 17
Cardiovascular Systems Inc, Key Competitors 19
Cardiovascular Systems Inc, Key Employees 20

List of Figures
Cardiovascular Systems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cardiovascular Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cardiovascular Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Cardiovascular Systems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cardiovascular Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cardiovascular Systems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Cardiovascular Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cardiovascular Systems Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Cardiovascular Systems Inc (CSII):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NanoViricides Inc (NNVC)-製薬・医療分野:企業M&A・提携分析
    Summary NanoViricides Inc (NanoViricides), formerly Edot-com.com Inc is a biopharmaceutical company that provides nanomedicine technology solutions. The company conducts research in the areas of medical science and pharmaceutical technology such as polymeric micelles, multi-specific multi-targeting, …
  • EQT Corporation:企業の戦略・SWOT・財務情報
    EQT Corporation - Strategy, SWOT and Corporate Finance Report Summary EQT Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Compugen Ltd (CGEN):企業の財務・戦略的SWOT分析
    Summary Compugen Ltd (Compugen) is a predictive drug discovery and development company that develops medicines for immuno-oncology and autoimmune diseases. The company’s immuno-oncology pipeline comprises COM701 and PVRIG; BAY 1905254, COM902 and TIGIT; and autoimmune diseases pipeline includes CGEN …
  • CytImmune Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CytImmune Sciences Inc (CytImmune) is a clinical stage nanomedicine company that discovers, develops, and commercializes tumor-targeted therapies. The company develops nanotherapy platform, Aurimune, a tumor-targeted trojan horse. Its Aurimune binds TNF receptors on blood vessel cells at the …
  • Perrigo Co Plc (PRGO):企業の財務・戦略的SWOT分析
    Perrigo Co Plc (PRGO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Cott Corporation:企業の戦略・SWOT・財務情報
    Cott Corporation - Strategy, SWOT and Corporate Finance Report Summary Cott Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • The Menarini Group:企業のM&A・事業提携・投資動向
    The Menarini Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Menarini Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Norfolk Southern Corporation:企業の戦略・SWOT・財務情報
    Norfolk Southern Corporation - Strategy, SWOT and Corporate Finance Report Summary Norfolk Southern Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Kajima Corporation:企業の戦略・SWOT・財務情報
    Kajima Corporation - Strategy, SWOT and Corporate Finance Report Summary Kajima Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Quidel Corp (QDEL)-医療機器分野:企業M&A・提携分析
    Summary Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays; molecular assays; virology products including traditional cell lines, specime …
  • NR Electric Co Ltd:企業の戦略的SWOT分析
    NR Electric Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • TETRA Technologies Inc (TTI):企業の財務・戦略的SWOT分析
    Summary TETRA Technologies Inc (TETRA) is an oil and gas company that offers completion fluids and associated products and services. The company’s services comprise compression services, fluid, filtration and tools services, offshore services, production testing, rig cooling services, technology cen …
  • Bosch Packaging Technology GmbH:企業の戦略・SWOT・財務情報
    Bosch Packaging Technology GmbH - Strategy, SWOT and Corporate Finance Report Summary Bosch Packaging Technology GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Excelsior Gold Limited (EXG):企業の財務・戦略的SWOT分析
    Excelsior Gold Limited (EXG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Baoding Lightway Green Energy Technology Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Baoding Lightway Green Energy Technology Co Ltd (Lightway), a subsidiary of LONGJITAIHE Group, is a vertically integrated solar module manufacturer. It specializes in the manufacture of high quality solar PV products, provides professional solutions and customer service. The company develops …
  • Ziehm Imaging GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Ziehm Imaging GmbH (Ziehm Imaging) is a medical device company that develops, produce and markets mobile X-ray based imaging solutions. The company's products include c-arms with flat panel detectors, c-arms with 3D imaging and c-arms with image intensifier. It offers Ziehm Vision RFD 3D, 3D …
  • Msc Industrial Direct Co., Inc.:企業の戦略・SWOT・財務分析
    Msc Industrial Direct Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Msc Industrial Direct Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Covagen AG-製薬・医療分野:企業M&A・提携分析
    Summary Covagen AG (Covagen), a subsidiary of Cilag GmbH International is a biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb technology. The company’s pipeline products include COVA 322, a bispecific anti-tumor necrosis factor alpha …
  • Detour Gold Corp:企業の戦略・SWOT・財務分析
    Detour Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Detour Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Summit Therapeutics Plc (SUMM)-製薬・医療分野:企業M&A・提携分析
    Summary Summit Therapeutics Plc (Summit), formerly Summit Corp Plc is a clinical-stage drug discovery and development company that offer therapies. The company conducts research and development on the treatment of rare diseases and infectious diseases including duchenne muscular dystrophy and the in …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆